BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15226088)

  • 21. Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis.
    Mesters RM; Flörke N; Ostermann H; Kienast J
    Thromb Haemost; 1996 Jun; 75(6):902-7. PubMed ID: 8822584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of hyperestrogenism during in vitro fertilization on the fibrinolytic mechanism.
    Lox C; Cañez M; Prien S
    Int J Fertil Womens Med; 1998; 43(1):34-9. PubMed ID: 9580312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in tissue plasminogen activator and plasminogen activator inhibitor during administration of nitroglycerine into internal thoracic artery in dogs with acute myocardial ischemia].
    Wu X; Wang CF; Sheng J; Zhu J
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep; 16(9):527-9. PubMed ID: 15355613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion.
    Speidl WS; Zeiner A; Nikfardjam M; Geppert A; Jordanova N; Niessner A; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
    J Am Coll Cardiol; 2005 Jan; 45(1):30-4. PubMed ID: 15629369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of the hemostasis in unstable angina pectoris].
    Lisowski P; Małyszko J; Lisowska A; Czech B; Myśliwiec M; Jackowski R; Hirnle T
    Pol Merkur Lekarski; 2004 May; 16(95):468-71. PubMed ID: 15518429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease.
    Robinson SD; Dawson P; Ludlam CA; Boon NA; Newby DE
    Clin Sci (Lond); 2006 Mar; 110(3):353-60. PubMed ID: 16309383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Difference in fibrinolytic activity between multivessel coronary spasm and one-vessel coronary spasm.
    Ogawa H; Suefuji H; Takazoe K; Soejima H; Sakamoto T; Miyamoto S; Kaikita K; Yoshimura M; Kugiyama K; Yasue H
    Am J Cardiol; 2000 Jan; 85(1):98-101, A8. PubMed ID: 11078245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis.
    Hennan JK; Elokdah H; Leal M; Ji A; Friedrichs GS; Morgan GA; Swillo RE; Antrilli TM; Hreha A; Crandall DL
    J Pharmacol Exp Ther; 2005 Aug; 314(2):710-6. PubMed ID: 15860572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dynamic changes of plasma tissue-type plasminogen activator level and the activity of its inhibitor during coronary vasospasm.
    Aoyama T; Yui Y; Takatsu Y; Takahashi M; Murohara Y; Shirotani M; Yasumoto H; Morishita H; Kadota K; Sakaguchi K
    Jpn Circ J; 1990 Sep; 54(9):1139-46. PubMed ID: 2125083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Instability mechanisms in unstable angina according to baseline serum levels of C-reactive protein: the role of thrombosis, fibrinolysis and atherosclerotic burden.
    Niccoli G; Biasucci LM; Biscione C; Buffon A; Siviglia M; Conte M; Porto I; Graziani F; Liuzzo G; Crea F
    Int J Cardiol; 2007 Nov; 122(3):245-7. PubMed ID: 17270293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet hyperaggregability persists even after the improvement of increased blood coagulation and impaired fibrinolysis with the stabilization of symptoms in patients with unstable angina.
    Miyamoto S; Ogawa H; Sakamoto T; Soejima H; Takazoe K; Shimomura H; Kajiwara I; Yoshimura M; Kugiyama K; Nakamura S; Ozaki Y
    Int J Cardiol; 2001; 80(2-3):235-42. PubMed ID: 11578720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study on the action of vitamin E supplementation on plasminogen activator inhibitor type 1 and platelet nitric oxide production in type 2 diabetic patients.
    Vignini A; Nanetti L; Moroni C; Testa R; Sirolla C; Marra M; Manfrini S; Fumelli D; Marcheselli F; Mazzanti L; Rabini RA
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):15-22. PubMed ID: 17949955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of beta-blockade.
    Teger-Nilsson AC; Larsson PT; Hjemdahl P; Olsson G
    Circulation; 1991 Dec; 84(6 Suppl):VI72-7. PubMed ID: 1683612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved fibrinolysis after one year of treatment with enalapril in men and women with uncomplicated myocardial infarction.
    Boman KO; Jansson JH; Nyhlén KA; Nilsson TK
    Thromb Haemost; 2002 Feb; 87(2):311-6. PubMed ID: 11859853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of metoprolol treatment on sympatho-adrenal activation of fibrinolysis.
    Larsson PT; Wiman B; Olsson G; Angelin B; Hjemdahl P
    Thromb Haemost; 1990 Jun; 63(3):482-7. PubMed ID: 2119530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein(a) levels in patients with unstable angina and their relationship with atherothrombosis and myocardial damage.
    Yazici M; Demircan S; Durna K; Sahin M
    Int J Clin Pract; 2005 Feb; 59(2):150-5. PubMed ID: 15854189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study.
    Crowther MA; Roberts J; Roberts R; Johnston M; Stevens P; Skingley P; Patrassi GM; Sartori MT; Hirsh J; Prandoni P; Weitz JI; Gent M; Ginsberg JS
    Thromb Haemost; 2001 Mar; 85(3):390-4. PubMed ID: 11307802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supplementation with orange and blackcurrant juice, but not vitamin E, improves inflammatory markers in patients with peripheral arterial disease.
    Dalgård C; Nielsen F; Morrow JD; Enghusen-Poulsen H; Jonung T; Hørder M; de Maat MP
    Br J Nutr; 2009 Jan; 101(2):263-9. PubMed ID: 18507878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
    Salobir B; Sabovic M; Zupan IP; Ponikvar JB
    Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasminogen activator inhibitor 1: a new prognostic marker in septic shock.
    Pralong G; Calandra T; Glauser MP; Schellekens J; Verhoef J; Bachmann F; Kruithof EK
    Thromb Haemost; 1989 Jun; 61(3):459-62. PubMed ID: 2678584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.